The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Queries multiple resources authors HGNC (2019) <https://www.genenames.org>, authors limma (2015) <doi:10.1093/nar/gkv007> to find the correspondence between evolving nomenclature of human gene symbols, aliases, previous symbols or synonyms with stable, curated gene entrezID from NCBI database. This allows fast, accurate and up-to-date correspondence between human gene expression datasets from various date and platform (e.g: gene symbol: BRCA1 - ID: 672).
| Version: | 0.1.2 |
| Imports: | doParallel, limma, utils, org.Hs.eg.db, AnnotationDbi, parallel, foreach, readr, RCurl |
| Suggests: | spelling |
| Published: | 2021-02-15 |
| DOI: | 10.32614/CRAN.package.aliases2entrez |
| Author: | Raphael Bonnet [aut, cre] (Université Côte d’Azur), Lee Mariault [ctb] (Université Côte d’Azur), Jean-François Peyron [aut] (Inserm) |
| Maintainer: | Raphael Bonnet <raphael.bonnet at univ-cotedazur.fr> |
| BugReports: | https://github.com/peyronlab/aliases2entrez/issues |
| License: | MIT + file LICENSE |
| NeedsCompilation: | no |
| Language: | en-US |
| Materials: | NEWS |
| In views: | Omics |
| CRAN checks: | aliases2entrez results |
| Reference manual: | aliases2entrez.pdf |
| Package source: | aliases2entrez_0.1.2.tar.gz |
| Windows binaries: | r-devel: aliases2entrez_0.1.2.zip, r-release: aliases2entrez_0.1.2.zip, r-oldrel: aliases2entrez_0.1.2.zip |
| macOS binaries: | r-release (arm64): aliases2entrez_0.1.2.tgz, r-oldrel (arm64): aliases2entrez_0.1.2.tgz, r-release (x86_64): aliases2entrez_0.1.2.tgz, r-oldrel (x86_64): aliases2entrez_0.1.2.tgz |
| Old sources: | aliases2entrez archive |
Please use the canonical form https://CRAN.R-project.org/package=aliases2entrez to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.